Bibliography
- Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51
- Kassner PD. Discovery of novel targets with high throughput RNA interference screening. Comb.Chem.High Throughput Screen 2008;11:175-88
- Wiltgen M, Tilz GP. DNA microarray analysis: principles and clinical impact. Hematology 2007;12:271-87
- Flotte TR. Gene therapy: the first two decades and the current state-of-the-art. J Cell Physiol 2007;213:301-5
- Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2005;2:255-68
- Knapp JE, Liu D. Hydrodynamic delivery of DNA. Methods Mol Biol 2004;245:245-50
- Elouahabi A, Ruysschaert JM. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther 2005;11:336-47
- Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006;58:32-45
- Mastrobattista E, van Der Aa MA, Hennink WE, Crommelin DJ. Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov 2006;5:115-21
- Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7
- Xu Y, Hui SW, Frederik P, Szoka FC Jr. Physicochemical characterization and purification of cationic lipoplexes. Biophys J 1999;77:341-53
- Radler JO, Koltover I, Salditt T, Safinya CR. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 1997;275:810-4
- Mahato RI, Kim SW. Pharmaceutical perspectives of nucleic acid-based therapeutics. London: Taylor & Francis; 2002
- Edelstein ML, Abedi MR, Wixon J, Edelstein RM. Gene therapy clinical trials worldwide 1989-2004 – an overview. J Gene Med 2004;6:597-602
- Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007 – an update. J Gene Med 2007;9:833-42
- Zhang S, Xu Y, Wang B, et al. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Rel 2004;100:165-80
- El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Rel 2004;94:1-14
- Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 2005;7:E61-77
- Li W, Szoka FC Jr. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 2007;24:438-49
- Lv H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Rel 2006;114:100-9
- Karmali PP, Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises. Med Res Rev 2007;27:696-722
- Pinnaduwage P, Schmitt L, Huang L. Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochim Biophys Acta 1989;985:33-7
- Tang F, Hughes JA. Synthesis of a single-tailed cationic lipid and investigation of its transfection. J Control Rel 1999;62:345-58
- Liu D, Qiao W, Li Z, et al. Structure-function relationship research of glycerol backbone-based cationic lipids for gene delivery. Chem Biol Drug Des.2008;71:336-44
- Wang L, Koynova R, Parikh H, MacDonald RC. Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy. Biophys J 2006;91:3692-706
- Koynova R, Wang L, MacDonald RC. An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents. Proc Natl Acad Sci USA 2006;103:14373-8
- Heyes J, Palmer L, Bremner K, MacLachlan I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Rel 2005;107:276-87
- Heyes JA, Niculescu-Duvaz D, Cooper RG, Springer CJ. Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer. J Med Chem 2002;45:99-114
- Floch V, Loisel S, Guenin E, et al. Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity. J Med Chem 2000;43:4617-28
- Bajaj A, Mishra SK, Kondaiah P, Bhattacharya S. Effect of the headgroup variation on the gene transfer properties of cholesterol based cationic lipids possessing ether linkage. Biochim Biophys Acta 2007
- Ghosh YK, Visweswariah SS, Bhattacharya S. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency. FEBS Lett 2000;473:341-4
- Ghosh YK, Visweswariah SS, Bhattacharya S. Advantage of the ether linkage between the positive charge and the cholesteryl skeleton in cholesterol-based amphiphiles as vectors for gene delivery. Bioconjug Chem 2002;13:378-84
- Niculescu-Duvaz D, Heyes J, Springer CJ. Structure-activity relationship in cationic lipid mediated gene transfection. Curr Med Chem 2003;10:1233-61
- Rajesh M, Sen J, Srujan M, et al. Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery. J Am Chem Soc 2007;129:11408-20
- Liu D, Hu J, Qiao W, et al. Synthesis of carbamate-linked lipids for gene delivery. Bioorg Med Chem Lett 2005;15:3147-50
- Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994;269:2550-61
- Hafez IM, Maurer N, Cullis PR. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther 2001;8:1188-96
- Fletcher S, Ahmad A, Price WS, et al. Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene delivery. Chembiochem 2008;9:455-63
- De Laporte L, Cruz RJ, Shea LD. Design of modular non-viral gene therapy vectors. Biomaterials 2006;27:947-54
- del Pozo-Rodriguez A, Delgado D, Solinis MA, et al. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int J Pharm 2007;339:261-8
- Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 2006;116:255-64
- Kawakami S, Higuchi Y, Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci 2008;97:726-45
- Kawakami S, Fumoto S, Nishikawa M, et al. in vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res 2000;17:306-13
- Fumoto S, Nakadori F, Kawakami S, et al. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver. Pharm Res 2003;20:1452-9
- Fumoto S, Kawakami S, Ito Y, et al. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol Ther 2004;10:719-29
- Audouy S, Molema G, de LL, Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J Gene Med 2000;2:465-76
- Yew NS, Scheule RK. Toxicity of cationic lipid-DNA complexes. Adv Genet 2005;53:189-214
- Milano Politecnico. New cationic lipid compound capable of forming complexes with nucleic acids for use in nanoparticles for preparation of gene therapy remedy or for transfection of eukariotic cells. WO2006087752; 2006
- Expression Genetics, Inc. Biodegradable cross-linked cationic multi-block copolymer of lineal poly(alkylenimine) and hydrophilic linker, useful for administering drug blooded animal, and for transfecting cells. WO2006052649; 2006
- Balaban At Swimteea. New pyridinium cationic lipids (e.g. 1-(2,3-dihydroxypropyl)- 2,4,6-trimethylpyridinium hexafluorophosphate) useful as gene transfer agents in the treatment of lung cancer and cystic fibrosis. US2005196863; 2005
- Chemi Spa. Process for synthesis of cationic lipids useful e.g. carrier for intracellular release of gene materials involves quarternizing lipid mono tosylate derivative with tertiary amine in presence of alcoholic solvent. WO2005049549; 2005
- Univ Ruhr Bochum KTG. New lipid with serine backbone useful for preparing an agent e.g. agent for gene therapy for transferring a biologically active molecule into cells and/or tissues in vitro EP1457483; 2004
- CNRS Cent Nat Rech Sci IINS&RMUBOUBCH. New lipophilic cationic compounds containing phosphoric acid diester-amide and onium moieties, useful as nucleic acid transfection lipids having low cytotoxicity, for use in vitro or in vivo. WO2004043970; 2004
- Von Kiedrowski G Lkjpmuba. Composition for transferring biologically active molecules into cells or tissues, especially for gene therapy, comprises a diol-functional cationic lipid. WO2003030945; 2003
- Sterrendbeld Biotechnologie North America. New cholesterol derived amphiphilic cationic lipids, useful for gene transfer or medical treatments based on gene therapy. WO2003035669; 2006
- Herscovici J, Schermand D, Tranchant I, et al. New poly-thiourea derivative transfection lipid compounds, useful for transferring nucleic acids into cells, e.g. for gene therapy. WO200292558; 2002
- Life Technologies, Inc. New peptide comprising Tat sequence linked to nucleic acid-binding group, useful, e.g. in gene therapy, for improving cell-transfection efficiency. US6376248; 2002
- Aventis Pharma SA, Sherman D, Bessodes M, et al. New higher alkyl-substitued oligo-benzimidazole derivatives, useful as nucleic acid transfection agents detectable by fluorescence, e.g. for use in gene therapy. WO200132630; 2001
- IC Vec Ltd, Mitsubishi Chem Corp, Miller AD, Jorgensen MR, et al. New carbohydrate compounds capable of acting as cationic lipids, useful in treatment of genetic disorder, condition or disease, comprises a cholesterol group and a carbohydrate moiety. WO200248380; 2002
- Park JS, Choi JS, Lee EJ, Jang HS. Cationic lipids for gene transfer and their preparation, useful for transfection cell with exogenous DNA. WO200073471; 2000
- Peeters L, Sanders NN, Jones A, et al. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J Control Release 2007;121:208-17
- Jeong JH, Kim SH, Kim SW, Park TG. Intracellular delivery of poly(ethylene glycol) conjugated antisense oligonucleotide using cationic lipids by formation of self-assembled polyelectrolyte complex micelles. J Nanosci Nanotechnol 2006;6:2790-5
- Meyer O, Kirpotin D, Hong K, et al. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J Biol Chem 1998;273:15621-7
- Rejman J, Wagenaar A, Engberts JB, Hoekstra D. Characterization and transfection properties of lipoplexes stabilized with novel exchangeable polyethylene glycol-lipid conjugates. Biochim Biophys Acta 2004;1660:41-52
- Genzyme Corp. Preparing micellar complexes. WO9965461; 1999
- Tousignant JD, Eastman SJ, Lee ER, et al. Cationic micellar complex for delivering biologically active molecules to target cells, especially airway epithelial cells, comprises a cationic lipid, biologically active molecule and polyethylene glycol derivative. US20001048940; 2001
- Schiffelers RM, de Wolf HK, van Rooy I, Storm G. Synthetic delivery systems for intravenous administration of nucleic acids. Nanomed 2007;2:169-81
- Budker V, Gurevich V, Hagstrom JE, et al. pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nat Biotechnol 1996;14:760-4
- Kabanov AV, Felgner PL, Seymour LW. Self-assembling complexes for gene delivery from laboratory to clinical trial. Chichester: Wiley; 1998
- Novosom AG, Essler F, Panzner S, Endert G. New pH sensitive cationic lipids e.g. used in liposomes for drug delivery or gene transfer, comprise heterocyclic cation linked through spacer to 2,3-diacyloxypropyl amphiphile. WO2003070220; 2003
- Inex Pharm Corp. Preparing cationic liposome-nucleic acid complexes of controlled, small size- by incubation at low temperature, useful for introducing DNA into cells, ex vivo or in vivo, particularly for gene therapy. WO9841192; 1998
- Sequus Pharm, Inc. AC. Liposome composition for in vivo administration of poly:nucleotide-comprises suspension of liposomes composed of bilayer membrane formed of cationic vesicle-forming lipid and core comprising poly: nucleotide. WO9858630; 1998
- Sigma-Tau Ind Farm Riunite Spa. New perfluorinted alkanoyl-carnitine esters useful for production of liposomes. WO9957094; 1999
- Aventis Pharma Deutz GmbH. Liposomal vector complex, useful in gene therapy, comprises nucleic acid sequence, cationic carrier and (phosphor)lipid components. WO200074646; 2000
- Mitsubishi Chem Corp, Fletcher S, Jorgensen MR, Miller AD. Compositions comprising lipids comprising a polar and non polar moiety and active agent, also liposomes and compounds, useful in gene therapy, especially gene delivery. WO2003011252; 2003
- Inex Pharm Corp. Production of serum-stable lipid-encapsulated plasmid particles useful for transfecting cells in vitro or in vivo, especially for gene therapy. US5981501; 2000
- Boehringer Ingelheim Int. Composition containing nucleic acid complexed with cationic lipid and a membrane-active, acidic peptide-used to increase efficiency of transfection by destabilising the endosomal membrane, especially useful for gene therapy. WO9730170; 1997
- Roche Diagnostics Gmbh. New conjugate of lipid with basic, membrane-disrupting peptide having reversed amide backbone, used to introduce anionic macromolecules or active agents into cells, e.g. for gene therapy. WO9951629; 1999
- Implyx Ltd. Composition comprising conjugate of DNA-binding protein and polynucleotide, useful in gene therapy, is free of serum, calcium and chloroquine. WO200176638; 2001
- Mirus Corp. Amphipathic polyamine compounds comprising alkyl, alkenyl or lipid groups, useful for forming terciary complexes with DNA and DNA-binding proteins, e.g. histones H1, H2A, H2B, H3 or H4, for transfecting cells, e.g. for gene therapy. US6180784; 2001
- Ross PC, Hui SW. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther 1999;6:651-9
- Pelisek J, Gaedtke L, DeRouchey J, et al. Optimized lipopolyplex formulations for gene transfer to human colon carcinoma cells under in vitro conditions. J Gene Med 2006;8:186-97
- Madeira C, Loura LM, Prieto M, et al. Effect of ionic strength and presence of serum on lipoplexes structure monitorized by FRET. BMC Biotechnol 2008;8:20
- Madeira C, Loura LM, Prieto M, et al. Liposome complexation efficiency monitored by FRET: effect of charge ratio, helper lipid and plasmid size. Eur Biophys J 2007;36:609-20
- Hama S, Akita H, Ito R, et al. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 2006;13:786-94
- Segura T, Shea LD. Materials for non-viral gene delivery. Ann Rev Mater Res 2001;31:25-46
- Han SE, Kang H, Shim GY, et al. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int J Pharm 2008;353:260-9
- John M, Constien R, Akinc A, et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 2007;449:745-7
- Wagner E. Advances in cancer gene therapy: tumor-targeted delivery of therapeutic pDNA, siRNA, and dsRNA nucleic acids. J BUON 2007;12(Suppl 1):S77-82
- Galanis E, Burch PA, Richardson RL, et al. Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma. Cancer 2004;101:2557-66
- Gonzalez R, Hutchins L, Nemunaitis J, et al. Phase 2 trial of Allovectin-7 in advanced metastatic melanoma. Melanoma Res 2006;16:521-6